Wawersik; Stefan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wawersik; Stefan.The latest application filed is for "methods for treating metabolic diseases by inhibiting myostatin activation".

Company Profile

6.6.12

Wawersik; Stefan - Westborough MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
LTBP complex-specific inhibitors of TGF.beta. and uses thereof Grant 11,365,245 - Schurpf , et al. June 21, 2	2022-06-21
Methods For Treating Metabolic Diseases By Inhibiting Myostatin Activation App 20220106390 - DONOVAN; Adriana ; et al.	2022-04-07
LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOF App 20220064276 - SCHURPF; Thomas ; et al.	2022-03-03
Isoform-selective Tgfb1 Inhibitors And Use Thereof App 20220064275 - DATTA; Abhishek ; et al.	2022-03-03
LTBP complex-specific inhibitors of TGF.beta. and uses thereof Grant 11,214,614 - Schurpf , et al. January 4, 2	2022-01-04
Tgf 1 Inhibitors And Use Thereof App 20210340238 - Datta; Abhishek ; et al.	2021-11-04
Methods For Inhibiting Myostatin Activation By Administering Anti-pro/latent Myostatin Antibodies App 20210332117 - Donovan; Adriana ; et al.	2021-10-28
Compositions and methods for making and using anti-myostatin antibodies Grant 11,155,611 - Donovan , et al. October 26, 2	2021-10-26
Isoform-selective TGF.beta.1 inhibitors and use thereof Grant 11,130,803 - Datta , et al. September 28, 2	2021-09-28
High-affinity, Isoform-selective Tgf 1 Inhibitors And Use Thereof App 20210122814 - Datta; Abhishek ; et al.	2021-04-29
LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOF App 20210047396 - Schurpf; Thomas ; et al.	2021-02-18
Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies Grant 10,882,904 - Donovan , et al. January 5, 2	2021-01-05
Lrrc33 Inhibitors And Use Thereof App 20200181251 - Buckler; Alan ; et al.	2020-06-11
Isoform-selective Tgfb1 Inhibitors And Use Thereof App 20200079840 - Datta; Abhishek ; et al.	2020-03-12
Methods For Treating Metabolic Diseases By Inhibiting Myostatin Activation App 20190345239 - DONOVAN; Adriana ; et al.	2019-11-14
Methods For Inhibiting Myostatin Activation By Administering Anti-pro/latent Myostatin Antibodies App 20190218283 - Donovan; Adriana ; et al.	2019-07-18
Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies Grant 10,287,345 - Donovan , et al.	2019-05-14
Anti-pro/latent Myostatin Antibodies And Methods Of Use Thereof App 20170198032 - Donovan; Adriana ; et al.	2017-07-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.